塔科苏博心肌病的外科手术管理:一个概述
Marta Pillitteri1, Etrusca Brogi2, Chiara Piagnani1
1Department of Anaesthesia and Intensive Care, University of Pisa, Pisa, Italy.
Journal of anesthesia, analgesia and critical care
|July 15, 2024
概括
压力引起的心脏病,Takotsubo心肌病,经常发生在手术期间. 麻醉科医生必须了解其在外科手术期间的管理.
科学领域:
- 心脏病学 心脏病学
- 麻醉学 麻醉学
- 心血管研究研究心血管研究
背景情况:
- 塔科茨博心肌病 (TTC) 呈现为左心室上垂体气球膨胀和基底运动过度,类似于日本多体血管.
- 这种状况与心肌中的β-上腺素受体敏感度增加有关,增加了对catecholamine波动的敏感性.
- 严重的情绪或身体压力经常引发TTC,在外科手术期间的发病率上升.
研究的目的:
- 为了提供一个全面的概述塔科苏博综合征.
- 讨论Takotsubo心肌病患者的外科手术期间管理策略.
- 突出麻醉师在手术过程中和手术前管理应激心肌病的作用.
主要方法:
- 关于Takotsubo心肌病症病理生理学和临床表现的文献综述.
- 对TTC目前的治疗方法和指导方针 (或缺乏) 的分析.
- 讨论在手术环境中麻醉学的考虑和管理策略.
主要成果:
- 塔科茨布心肌病越来越多地在外科手术期间被诊断出来,这给麻醉管理带来了挑战.
- 手术,麻醉诱导和严重疾病被确定为压力心肌病的潜在触发因素.
- 目前的治疗严重依赖临床经验,因为缺乏普遍接受的指导方针.
结论:
- 麻醉科医生在治疗接受手术的新发病或先前存在的Takotsubo心肌病患者中发挥着至关重要的作用.
- 了解TTC的触发因素和病理生理学对于安全的术后护理至关重要.
- 需要进一步的研究和标准化指导方针,以优化手术患者的Takotsubo心肌病管理.
更多相关视频
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
8.5K
09:12Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
Published on: March 27, 2018
9.4K
相关概念视频
Heart Failure Drugs: Inotropic Agents
564
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
564
Increased pulse rate
651
Tachycardia is a condition marked by an abnormally fast or irregular heart rate, surpassing the typical resting rate. In adults, tachycardia is characterized by a pulse rate ranging from 100 to 180 beats per minute. The increased heart rate can result in inadequate blood flow to various body parts, ultimately diminishing the oxygen supply to organs and tissues.
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
651
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
419
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
419
